Chargement en cours...
The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Current research indicates that the next silent epidemic will be linked to chronic liver diseases, specifically non-alcoholic fatty liver disease (NAFLD), which was renamed as metabolic-associated fatty liver disease (MAFLD) in 2020. Globally, MAFLD mortality is on the rise. The etiology of MAFLD is...
Enregistré dans:
| Publié dans: | Pharmaceuticals (Basel) |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8001129/ https://ncbi.nlm.nih.gov/pubmed/33806527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14030215 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|